Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vermilion Life Sciences is a UK-based strategic consultancy specializing in the reengineering of medicines development, a methodology it terms #ReMedDev. Founded by Dr. Stuart Dollow, a former senior executive at major pharmaceutical firms including GSK, Roche, and Takeda, the company provides expert advisory services to pharmaceutical companies, biotechnology firms, and medical research charities. Its core offerings include portfolio management, regulatory strategy, clinical development planning, and pharmacovigilance. The firm is recognized for its focus on streamlining the path for new therapies to reach patients and its active participation in industry-wide innovation initiatives such as the Pistoia Alliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vermillion Life Sciences.